NCT00302744 2025-03-13
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 1/2 Completed
Clinical Trials
5 trialsNCT03076437 2021-03-19
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
Shenzhen Institute for Innovation and Translational Medicine
Phase 1/2 Completed
NCT00095706 2015-09-25
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
Translational Oncology Research International
Phase 1/2 Completed
NCT01711398 2015-02-12
IP N02
Elro Pharma
Phase 1/2 Completed
NCT00087854 2008-04-23
Study of Individualized Amonafide to Treat Prostate Cancer
Xanthus Pharmaceuticals, Inc.
Phase 1/2 Completed